Scientific Programme Saturday 5 September 2020

08.15-08.30 
Aguiar
ESVE-O-7
08.30-08.45 
Scharf
ESVE-O-8
08.45-09.00 
Jankovic
ESVE-O-9

09.00-09.15 
Gerou-Ferriani
ESVE-O-10
09.15-09.30 
van Bokhorst
ESVE-O-11
09.30-09.45 
Hazuchova
ESVE-O-12

09.45-10.00 
Linari
ESVE-O-13
10.00-10.15 
Krämer
ESVE-O-14
10.15-10.30 
Miceli
ESVE-O-15

Barbara Willi (CH)
Infection prevention and control in veterinary settings

10.30-11.15

BREAK

11.20-11.35
Sanders
ESVE-O-16
11.35-11.50
Corsini
ESVE-O-17
11.50-12.05 
Gomes
ESVE-O-18

Fiona Thomson (GB)
Could liquid biopsies change the face of cancer treatment? Learnings from human clinical studies

Peter Damborg (DK)
European Network for Optimization of Veterinary Antimicrobial Treatment

12.05-12.20
Foster
ESVE-O-19
12.20-12.35
Veldhuizen
ESVE-O-20
12.35-12.50 
Schofield
ESVE-O-21

Scott Weese (CAN)
The relevance of MDR bacteria in veterinary hospitals

12.50-14.20

BREAK

Chen Gilor (US)
Insulin analogues and alternatives to insulin in diabetes – experience in veterinary medicine

14.25-14.40
Marconato
ESVONC-O-1
14.40-14.55
Boyé
ESVONC-O-2
14.55-15.10 
Treggiari
ESVONC-O-3

Chen Gilor (US)
Lessons learned from ‘Wearable Tech’ in canine and feline diabetes

15.10-15.25
Beaudu-Lange
ESVONC-O-4
15.25-15.40 
Williams
ESVONC-O-5
15.40-15.55 
Attorri
ESVONC-O-6

15.55-16.25

BREAK

Federico Fracassi (I)
FreeStyle Libre in veterinary diabetology

16.30-16.45
Mosca
ESVONC-O-7
16.45-17.00
Arendt
ESVONC-O-8
17.00-17.15 
Kreilmeier-Berger
ESVONC-O-9

Masterclass
Sydney Moise (US)
ECG Interpretation from basic to advanced 
Continued 

Concetta Irace (I)
‘Wearable Tech’ and new technologies in the management of diabetes mellitus in humans

17.15-17.30
Best
ESVONC-O-10
17.30-17.45
Espada Castro
ESVONC-O-11